Hypothetical case - For market research purposes only
UNITED BY CANCER
About UsOur TreatmentsOur Science
Our StoryEventsResources
Profile
Search
You are about to enter Our Science, which contains information concerning our Research & Development activities as well as other information produced by our Medical Affairs function.
You are about to enter Our Treatments, which contains information promoting the use of our approved medicines.

The DREAMM-5 Clinical Trial

Download pdf
[432 Kb]

Learn more about DREAMM-5, an ongoing trial investigating belantamab mafodotin-blmf as monotherapy and in combination with anti-cancer treatments in participants with relapsed/refractory multiple myeloma.

_

_